These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22366757)

  • 21. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin receptors - from molecular biology to clinical applications.
    Pytliak M; Vargová V; Mechírová V; Felšöci M
    Physiol Res; 2011; 60(1):15-25. PubMed ID: 20945968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A developmental characterization of mesolimbocortical serotonergic gene expression changes following early immune challenge.
    Sidor MM; Amath A; MacQueen G; Foster JA
    Neuroscience; 2010 Dec; 171(3):734-46. PubMed ID: 20816924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.
    Murphy DL
    Neuropsychopharmacology; 1990; 3(5-6):457-71. PubMed ID: 2078279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin and stress.
    Chaouloff F; Berton O; Mormède P
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):28S-32S. PubMed ID: 10432486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the serotonergic system in motor control.
    Kawashima T
    Neurosci Res; 2018 Apr; 129():32-39. PubMed ID: 28774814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early dysfunction of central 5-HT system in a murine model of bovine spongiform encephalopathy.
    Vidal C; Herzog C; Haeberle AM; Bombarde C; Miquel MC; Carimalo J; Launay JM; Mouillet-Richard S; Lasmézas C; Dormont D; Kellermann O; Bailly Y
    Neuroscience; 2009 Jun; 160(4):731-43. PubMed ID: 19285121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin controls initiation of locomotion and afferent modulation of coordination via 5-HT
    Cabaj AM; Majczyński H; Couto E; Gardiner PF; Stecina K; Sławińska U; Jordan LM
    J Physiol; 2017 Jan; 595(1):301-320. PubMed ID: 27393215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics and the serotonin system: initial studies and future directions.
    Veenstra-VanderWeele J; Anderson GM; Cook EH
    Eur J Pharmacol; 2000 Dec; 410(2-3):165-181. PubMed ID: 11134668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications.
    Russo S; Kema IP; Bosker F; Haavik J; Korf J
    World J Biol Psychiatry; 2009; 10(4):258-68. PubMed ID: 19921967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Brain-derived neurotrophic factor: the influence on the genetically and epigenetically determined behavioral disorders].
    Popova NK; Morozova MV
    Ross Fiziol Zh Im I M Sechenova; 2013 Oct; 99(10):1125-37. PubMed ID: 25434225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors.
    Béïque JC; Campbell B; Perring P; Hamblin MW; Walker P; Mladenovic L; Andrade R
    J Neurosci; 2004 May; 24(20):4807-17. PubMed ID: 15152041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple serotonin receptors: clinical and experimental aspects.
    Roth BL
    Ann Clin Psychiatry; 1994 Jun; 6(2):67-78. PubMed ID: 7804391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic regulation of renin and prolactin secretion.
    Van de Kar LD; Rittenhouse PA; Li Q; Levy AD
    Behav Brain Res; 1996; 73(1-2):203-8. PubMed ID: 8788503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas.
    Benkelfat C
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():53-6. PubMed ID: 8201247
    [No Abstract]   [Full Text] [Related]  

  • 37. A dialogue between the immune system and brain, spoken in the language of serotonin.
    Baganz NL; Blakely RD
    ACS Chem Neurosci; 2013 Jan; 4(1):48-63. PubMed ID: 23336044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New tricks for an old slug: descending serotonergic system in pain.
    Wei F; Gu M; Chu YX
    Sheng Li Xue Bao; 2012 Oct; 64(5):520-30. PubMed ID: 23090493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of social experience on serotonergic modulation of the escape circuit of crayfish.
    Yeh SR; Fricke RA; Edwards DH
    Science; 1996 Jan; 271(5247):366-9. PubMed ID: 8553075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents.
    Glennon RA; Darmani NA; Martin BR
    Life Sci; 1991; 48(26):2493-8. PubMed ID: 2046474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.